Trademark: 97160294
Word
WINMILA
Status
Registered
Status Code
700
Status Date
Tuesday, January 3, 2023
Serial Number
97160294
Registration Number
6942753
Registration Date
Tuesday, January 3, 2023
Mark Type
4000
Filing Date
Tuesday, December 7, 2021
Published for Opposition
Tuesday, October 18, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
WIN MILA

Trademark Events
Oct 9, 2023
Teas Change Of Correspondence Received
Oct 9, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 9, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 9, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 9, 2023
Teas Change Of Owner Address Received
Jan 3, 2023
Notice Of Registration Confirmation Emailed
Jan 3, 2023
Registered-Principal Register
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 18, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2022
Published For Opposition
Sep 28, 2022
Notification Of Notice Of Publication E-Mailed
Sep 14, 2022
Approved For Pub - Principal Register
Sep 14, 2022
Examiner's Amendment Entered
Sep 14, 2022
Notification Of Examiners Amendment E-Mailed
Sep 14, 2022
Examiners Amendment E-Mailed
Sep 14, 2022
Examiners Amendment -Written
Sep 13, 2022
Assigned To Examiner
Dec 13, 2021
New Application Office Supplied Data Entered
Dec 10, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24